PetMed Gross Profit from 2010 to 2024

PETS Stock

USD 4.64 0.06 1.31%

PetMed Express Gross Profit yearly trend continues to be comparatively stable with very little volatility. Gross Profit will likely drop to about 72.2 M in 2024. Gross Profit is the profit PetMed Express makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2000-03-31

Previous Quarter

16.2 M

Current Value

19 M

Quarterly Volatility

6.9 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check PetMed Express financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PetMed Express' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.4 M, Interest Expense of 3.6 M or Selling General Administrative of 58 M, as well as many indicators such as Price To Sales Ratio of 0.32, Dividend Yield of 0.14 or PTB Ratio of 0.94. PetMed financial statements analysis is a perfect complement when working with PetMed Express Valuation or Volatility modules.

Check out the analysis of PetMed Express Correlation against competitors.

For more information on how to buy PetMed Stock please use our How to Invest in PetMed Express guide.

Latest PetMed Express' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of PetMed Express over the last few years. Gross profit is a required income statement account that reflects total revenue of PetMed Express minus its cost of goods sold. It is profit before PetMed Express operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. PetMed Express' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PetMed Express' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 78.08 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

PetMed Gross Profit Regression Statistics

	Arithmetic Mean	75,776,350
	Geometric Mean	67,360,388
	Coefficient Of Variation	27.56
	Mean Deviation	10,467,441
	Median	78,076,000
	Standard Deviation	20,885,602
	Sample Variance	436.2T
	Range	92.2M
	R-Value	0.38
	Mean Square Error	402.4T
	R-Squared	0.14
	Significance	0.16
	Slope	1,768,508
	Total Sum of Squares	6106.9T

PetMed Gross Profit History

	2024	72.2 M
	2023	78.6 M
	2022	71 M
	2021	78.1 M
	2020	89.9 M
	2019	81.2 M
	2018	95.3 M

Other Fundumenentals of PetMed Express

Gross Profit Margin

PetMed Express Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Good Will	Intangible Assets	Current Deferred Revenue	Net Tangible Assets	Deferred Long Term Liab	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock	Long Term Investments
Total Assets		0.95	-0.91	0.89	0.74	0.76	0.55	0.94	-0.12	0.67	0.74	0.1	0.22	0.66	0.87	0.57	0.54	0.47	0.18	0.07	0.01
Total Stockholder Equity	0.95		-0.95	0.98	0.59	0.72	0.36	0.97	-0.08	0.67	0.68	-0.09	0.02	0.68	0.77	0.46	0.39	0.6	0.36	-0.16	-0.1
Net Debt	-0.91	-0.95		-0.92	-0.66	-0.62	-0.42	-0.94	0.07	-0.47	-0.71	0.1	-0.04	-0.44	-0.86	-0.6	-0.44	-0.67	-0.39	0.2	0.07
Retained Earnings	0.89	0.98	-0.92		0.5	0.69	0.25	0.96	-0.05	0.65	0.6	-0.19	-0.11	0.67	0.68	0.38	0.25	0.66	0.45	-0.29	-0.17
Accounts Payable	0.74	0.59	-0.66	0.5		0.54	0.94	0.62	-0.6	0.51	0.75	0.6	0.67	0.22	0.83	0.75	0.79	0.09	-0.32	0.46	0.59
Net Receivables	0.76	0.72	-0.62	0.69	0.54		0.45	0.66	-0.22	0.66	0.58	0.27	0.25	0.65	0.65	0.39	0.33	0.14	-0.07	0.18	0.14
Total Liab	0.55	0.36	-0.42	0.25	0.94	0.45		0.38	-0.75	0.48	0.68	0.82	0.88	0.12	0.69	0.7	0.88	-0.23	-0.61	0.71	0.79
Total Current Assets	0.94	0.97	-0.94	0.96	0.62	0.66	0.38		-0.06	0.62	0.57	-0.12	0.01	0.64	0.76	0.46	0.35	0.66	0.4	-0.2	-0.12
Short Term Debt	-0.12	-0.08	0.07	-0.05	-0.6	-0.22	-0.75	-0.06		-0.49	-0.43	-0.83	-0.8	0.0	-0.22	-0.37	-0.67	0.46	0.73	-0.62	-0.95
Common Stock	0.67	0.67	-0.47	0.65	0.51	0.66	0.48	0.62	-0.49		0.52	0.36	0.4	0.86	0.38	0.24	0.5	-0.07	-0.24	0.34	0.3
Property Plant Equipment	0.74	0.68	-0.71	0.6	0.75	0.58	0.68	0.57	-0.43	0.52		0.39	0.45	0.29	0.8	0.67	0.74	0.11	-0.18	0.29	0.37
Good Will	0.1	-0.09	0.1	-0.19	0.6	0.27	0.82	-0.12	-0.83	0.36	0.39		0.93	-0.04	0.29	0.41	0.73	-0.67	-0.93	0.93	0.94
Intangible Assets	0.22	0.02	-0.04	-0.11	0.67	0.25	0.88	0.01	-0.8	0.4	0.45	0.93		0.01	0.37	0.48	0.85	-0.6	-0.86	0.88	0.88
Current Deferred Revenue	0.66	0.68	-0.44	0.67	0.22	0.65	0.12	0.64	0.0	0.86	0.29	-0.04	0.01		0.26	0.01	0.14	0.14	0.1	0.05	-0.18
Net Tangible Assets	0.87	0.77	-0.86	0.68	0.83	0.65	0.69	0.76	-0.22	0.38	0.8	0.29	0.37	0.26		0.74	0.68	0.39	0.03	0.22	0.22
Deferred Long Term Liab	0.57	0.46	-0.6	0.38	0.75	0.39	0.7	0.46	-0.37	0.24	0.67	0.41	0.48	0.01	0.74		0.65	0.2	-0.15	0.31	0.4
Capital Surpluse	0.54	0.39	-0.44	0.25	0.79	0.33	0.88	0.35	-0.67	0.5	0.74	0.73	0.85	0.14	0.68	0.65		-0.23	-0.56	0.7	0.69
Net Invested Capital	0.47	0.6	-0.67	0.66	0.09	0.14	-0.23	0.66	0.46	-0.07	0.11	-0.67	-0.6	0.14	0.39	0.2	-0.23		0.9	-0.73	-0.58
Net Working Capital	0.18	0.36	-0.39	0.45	-0.32	-0.07	-0.61	0.4	0.73	-0.24	-0.18	-0.93	-0.86	0.1	0.03	-0.15	-0.56	0.9		-0.91	-0.86
Capital Stock	0.07	-0.16	0.2	-0.29	0.46	0.18	0.71	-0.2	-0.62	0.34	0.29	0.93	0.88	0.05	0.22	0.31	0.7	-0.73	-0.91		0.77
Long Term Investments	0.01	-0.1	0.07	-0.17	0.59	0.14	0.79	-0.12	-0.95	0.3	0.37	0.94	0.88	-0.18	0.22	0.4	0.69	-0.58	-0.86	0.77

Click cells to compare fundamentals

About PetMed Express Financial Statements

PetMed Express shareholders use historical fundamental indicators, such as Gross Profit, to determine how well the company is positioned to perform in the future. Although PetMed Express investors may analyze each financial statement separately, they are all interrelated. The changes in PetMed Express' assets and liabilities, for example, are also reflected in the revenues and expenses on on PetMed Express' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Gross Profit	78.6 M	72.2 M
Gross Profit Margin	0.28	0.39

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for PetMed Stock Analysis

When running PetMed Express' price analysis, check to measure PetMed Express' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetMed Express is operating at the current time. Most of PetMed Express' value examination focuses on studying past and present price action to predict the probability of PetMed Express' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetMed Express' price. Additionally, you may evaluate how the addition of PetMed Express to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC